BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 11652031)

  • 1. Academic-corporate ties in biotechnology: a quantitative study.
    Krimsky S; Ennis JG; Weissman R
    Sci Technol Human Values; 1991; 16(3):275-87. PubMed ID: 11652031
    [No Abstract]   [Full Text] [Related]  

  • 2. Profits and ethics clash in research on genetic coding.
    Fisher LM
    N Y Times Web; 1994 Jan; ():1, 18. PubMed ID: 11647947
    [No Abstract]   [Full Text] [Related]  

  • 3. Virus.
    Bazell R
    New Repub; 1992 Nov; 207(20):21-2. PubMed ID: 11659543
    [No Abstract]   [Full Text] [Related]  

  • 4. Biotechnology and the social reconstruction of molecular biology.
    Markle GE; Robin SS
    Sci Technol Human Values; 1985; 10(1):70-9. PubMed ID: 11650692
    [No Abstract]   [Full Text] [Related]  

  • 5. University/corporate research agreements.
    Hutt PB
    Technol Soc; 1983; 5(2):107-18. PubMed ID: 11650686
    [No Abstract]   [Full Text] [Related]  

  • 6. Truth is no longer its own reward.
    Kiernan V
    New Sci; 1997 Mar; 153(2071):11. PubMed ID: 11656626
    [No Abstract]   [Full Text] [Related]  

  • 7. Commercialization of research: so far.
    Aisenberg J
    Nature; 1982 Jun 24-30; 297(5868):617. PubMed ID: 11650535
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Non-starters and no brainers: an outside perspective.
    David EE
    Account Res; 1997; 5(4):255-63. PubMed ID: 11656992
    [No Abstract]   [Full Text] [Related]  

  • 9. Rights to life: are scientists wrong to patent genes?
    Gladwell M
    New Yorker; 1995 Nov; 71(36):120-4. PubMed ID: 11654950
    [No Abstract]   [Full Text] [Related]  

  • 10. University-industry relationships in genetic research: potential opportunities and pitfalls.
    Walsh ME; Graber GC; Wolfe AK
    Account Res; 1997; 5(4):265-82. PubMed ID: 11656993
    [No Abstract]   [Full Text] [Related]  

  • 11. Financial interests of authors in scientific journals: a pilot study of 14 publications.
    Krimsky S; Rothenberg LS; Stott P; Kyle G
    Sci Eng Ethics; 1996 Oct; 2(4):395-410. PubMed ID: 11657729
    [No Abstract]   [Full Text] [Related]  

  • 12. The life sciences and the public: is science too important to be left to the scientist?
    Goggin ML
    Politics Life Sci; 1984 Aug; 3(1):28-75. PubMed ID: 11649787
    [No Abstract]   [Full Text] [Related]  

  • 13. Ethical issues in funding and monitoring university research.
    Beauchamp TL
    Bus Prof Ethics J; 1992; 11(1):5-16. PubMed ID: 11659431
    [No Abstract]   [Full Text] [Related]  

  • 14. FDA issues concerning conflicts of interest.
    Kurt TL
    IRB; 1990; 12(5):6-9. PubMed ID: 11654003
    [No Abstract]   [Full Text] [Related]  

  • 15. University physician-researcher conflicts of interest: the inadequacy of current controls and proposed reform.
    Maatz CT
    High Technol Law J; 1992; 7():137-88. PubMed ID: 11659962
    [No Abstract]   [Full Text] [Related]  

  • 16. Public-private partnerships in biomedical research: resolving conflicts arising under the Federal Technology Transfer Act of 1986.
    Bulleit TN
    J Law Health; 1989-1990; 4(1):1-20. PubMed ID: 11652568
    [No Abstract]   [Full Text] [Related]  

  • 17. Academic values tested by MIT's new center.
    Lepkowski W
    Chem Eng News; 1982 Mar; 60(11):7-12. PubMed ID: 11650457
    [No Abstract]   [Full Text] [Related]  

  • 18. Value issues in biomedical science: public concerns and professional complacency.
    Bellett A
    Immunol Cell Biol; 1992 Dec; 70(Pt. 6):363-8. PubMed ID: 11652209
    [No Abstract]   [Full Text] [Related]  

  • 19. Can academia adapt to biotechnology's lure?
    Fox JL
    Chem Eng News; 1981 Oct; 59(41):39-44. PubMed ID: 11650512
    [No Abstract]   [Full Text] [Related]  

  • 20. Exploiting genetics.
    Budiansky S
    Nature; 1982 Jun 24-30; 297(5868):618. PubMed ID: 11650536
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.